发明名称 |
Anti-BCMA antibodies |
摘要 |
This invention provides antibodies that recognize the B Cell Maturation Antigen (BCMA) and that bind naïve B cells, plasma cells, and/or memory B cells. The invention further provides methods for depleting naïve B cells, plasma cells, and memory B cells, and for treating B cell-related disorders, including lymphomas and autoimmune diseases. |
申请公布号 |
US9034324(B2) |
申请公布日期 |
2015.05.19 |
申请号 |
US201013255610 |
申请日期 |
2010.03.10 |
申请人 |
BIOGEN IDEC MA INC. |
发明人 |
Kalled Susan L.;Hsu Yen-Ming |
分类号 |
A61K39/395;C07K16/28;A61K39/00 |
主分类号 |
A61K39/395 |
代理机构 |
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. |
代理人 |
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. |
主权项 |
1. An isolated antibody or antigen binding fragment thereof that binds to the polypeptide of SEQ ID NO:9, wherein the antibody or antigen binding fragment thereof comprises:
a) a variable domain comprising CDR1, CDR2, and CDR3 of the amino acid sequence of SEQ ID NO:1 and a variable domain comprising CDR1, CDR2, and CDR3 of the amino acid sequence of SEQ ID NO:2; b) a variable domain comprising CDR1, CDR2, and CDR3 of the amino acid sequence of SEQ ID NO:3 and a variable domain comprising CDR1, CDR2, and CDR3 of the amino acid sequence of SEQ ID NO:4, SEQ ID NO:11, or SEQ ID NO:12; c) a variable domain comprising CDR1, CDR2, and CDR3 of the amino acid sequence of SEQ ID NO:5 and a variable domain comprising CDR1, CDR2, and CDR3 of the amino acid sequence of SEQ ID NO:6; or d) a variable domain comprising CDR1, CDR2, and CDR3 of the amino acid sequence of SEQ ID NO:7 and a variable domain comprising CDR1, CDR2, and CDR3 of the amino acid sequence of SEQ ID NO:8. |
地址 |
Cambridge MA US |